Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 15, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 21.0B USD
- Positions
- 955
- Share of the ten largest
- 13.9%
The ten largest positions Q3 2021
- Salesforce 2.5%▼ −5.5%
- Uber 2.3%▲ +17.1%
- Meta Platforms 1.4%▲ +14.5%
- Twitter Inc 1.3%▲ +147.9%
- Booking Holdings 1.2%▲ +22.9%
- Mastercard 1.1%▲ +54.5%
- IBM 1.1%new
- Visa Inc. 1.0%▼ −23.5%
- Microsoft 1.0%▲ +98.4%
- Jabil 1.0%▼ 0.0%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q3 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| CRM Salesforce | 2.5% | 1,972,327 | 534.9M USD | −5.5% reduced | Q1 2021 3 quarters |
| V Visa Inc. | 1.0% | 951,341 | 211.9M USD | −23.5% reduced | Q3 2020 5 quarters |
| JBL Jabil | 1.0% | 3,437,800 | 200.7M USD | 0.0% reduced | Q2 2019 10 quarters |
| WDC Western Digital | 0.9% | 3,466,500 | 195.6M USD | −40.4% reduced | Q3 2020 5 quarters |
| ADI Analog Devices | 0.9% | 1,128,033 | 188.9M USD | −0.2% reduced | Q2 2020 6 quarters |
| Seagen Inc | 0.7% | 812,081 | 137.9M USD | −12.7% reduced | Q1 2021 3 quarters |
| GOOGL Alphabet Inc. (Class A) | 0.6% | 48,949 | 130.9M USD | −3.2% reduced | Q2 2020 6 quarters |
| Pagseguro Digital Ltd | 0.5% | 2,075,956 | 107.4M USD | −14.1% reduced | Q2 2020 6 quarters |
| Perrigo Co PLC | 0.5% | 2,232,700 | 105.7M USD | −12.1% reduced | Q1 2021 3 quarters |
| Zendesk Inc | 0.5% | 892,647 | 103.9M USD | −12.7% reduced | Q3 2020 5 quarters |
| Anaplan Inc | 0.5% | 1,699,674 | 103.5M USD | −25.2% reduced | Q2 2020 6 quarters |
| Nice Ltd | 0.5% | 342,000 | 97.1M USD | −21.6% reduced | Q3 2020 5 quarters |
| MCHP Microchip Technology | 0.4% | 499,147 | 76.6M USD | −1.3% reduced | Q2 2019 10 quarters |
| PANW Palo Alto Networks | 0.4% | 156,707 | 75.1M USD | −51.1% reduced | Q1 2018 15 quarters |
| Bill Com HLDGS Inc | 0.3% | 259,661 | 69.3M USD | −57.9% reduced | Q2 2020 6 quarters |
| MCD McDonald's | 0.3% | 284,009 | 68.5M USD | −11.8% reduced | Q1 2021 3 quarters |
| Bicycle Therapeutics PLC | 0.3% | 1,615,092 | 67.2M USD | −10.6% reduced | Q4 2019 8 quarters |
| Encompass Health Corp | 0.3% | 872,900 | 65.5M USD | −0.6% reduced | Q4 2020 4 quarters |
| JD JD.com (ADR) | 0.3% | 880,276 | 63.6M USD | −38.1% reduced | Q4 2018 12 quarters |
| AMD Advanced Micro Devices | 0.3% | 590,100 | 60.7M USD | −53.9% reduced | Q3 2020 5 quarters |
| CPRT Copart | 0.3% | 435,709 | 60.4M USD | −40.4% reduced | Q2 2019 10 quarters |
| Signature Bk New York N Y | 0.3% | 216,261 | 58.9M USD | −39.2% reduced | Q4 2020 4 quarters |
| KLAC KLA Corporation | 0.3% | 169,884 | 56.8M USD | −20.1% reduced | Q2 2021 2 quarters |
| Arvinas Inc | 0.3% | 674,900 | 55.5M USD | −38.6% reduced | Q1 2019 11 quarters |
| COF Capital One | 0.3% | 328,255 | 53.2M USD | −60.6% reduced | Q3 2015 25 quarters |
| Performance Food Group Co | 0.3% | 1,139,859 | 53.0M USD | −32.7% reduced | Q2 2019 10 quarters |
| PYPL PayPal | 0.2% | 199,472 | 51.9M USD | −7.9% reduced | Q2 2019 10 quarters |
| MSI Motorola Solutions | 0.2% | 220,979 | 51.3M USD | −3.2% reduced | Q1 2021 3 quarters |
| TDY Teledyne Technologies | 0.2% | 117,185 | 50.3M USD | −28.4% reduced | Q3 2020 5 quarters |
| Elastic N V | 0.2% | 330,800 | 49.3M USD | −68.6% reduced | Q2 2020 6 quarters |
| Crown HLDGS Inc | 0.2% | 488,170 | 49.2M USD | −30.3% reduced | Q3 2020 5 quarters |
| Alaska Air Group Inc | 0.2% | 767,198 | 45.0M USD | −14.9% reduced | Q2 2018 14 quarters |
| MCK McKesson Corporation | 0.2% | 225,100 | 44.9M USD | −1.6% reduced | Q3 2020 5 quarters |
| BIDU Baidu (ADR) | 0.2% | 282,848 | 43.5M USD | −66.1% reduced | Q4 2020 4 quarters |
| Ovintiv Inc | 0.2% | 1,309,582 | 43.1M USD | −10.2% reduced | Q3 2020 5 quarters |
| Tandem Diabetes Care Inc | 0.2% | 356,667 | 42.6M USD | −47.4% reduced | Q1 2021 3 quarters |
| Capri Holdings Limited | 0.2% | 868,218 | 42.0M USD | −25.8% reduced | Q3 2020 5 quarters |
| Splunk Inc | 0.2% | 273,800 | 39.6M USD | −4.5% reduced | Q1 2021 3 quarters |
| Brooks Automation Inc New | 0.2% | 378,799 | 38.8M USD | −10.3% reduced | Q2 2021 2 quarters |
| United Therapeutics Corp Del | 0.2% | 206,900 | 38.2M USD | −62.5% reduced | Q2 2021 2 quarters |
| ADSK Autodesk | 0.2% | 132,897 | 37.9M USD | −7.1% reduced | Q4 2020 4 quarters |
| Cirrus Logic Inc | 0.2% | 438,000 | 36.1M USD | −7.4% reduced | Q2 2021 2 quarters |
| Axalta Coating Sys Ltd | 0.2% | 1,218,138 | 35.6M USD | −5.9% reduced | Q2 2021 2 quarters |
| RSG Republic Services | 0.2% | 294,465 | 35.4M USD | −51.2% reduced | Q2 2020 6 quarters |
| Builders Firstsource Inc | 0.2% | 676,400 | 35.0M USD | −3.4% reduced | Q1 2021 3 quarters |
| SYF Synchrony Financial | 0.2% | 712,600 | 34.8M USD | −39.9% reduced | Q3 2018 13 quarters |
| Angi Inc | 0.2% | 2,811,113 | 34.7M USD | −18.2% reduced | Q2 2020 6 quarters |
| Suncor Energy Inc New | 0.2% | 1,656,700 | 34.4M USD | −12.6% reduced | Q3 2018 13 quarters |
| Equinor ASA | 0.2% | 1,346,426 | 34.3M USD | −19.2% reduced | Q3 2020 5 quarters |
| Smartsheet Inc | 0.2% | 493,200 | 33.9M USD | −64.5% reduced | Q2 2021 2 quarters |
| TMUS T-Mobile US | 0.2% | 261,667 | 33.4M USD | −34.3% reduced | Q2 2020 6 quarters |
| Seaworld Entmt Inc | 0.2% | 601,988 | 33.3M USD | −8.4% reduced | Q3 2020 5 quarters |
| Marathon Oil Corp | 0.2% | 2,419,118 | 33.1M USD | −27.0% reduced | Q1 2021 3 quarters |
| GPN Global Payments | 0.2% | 207,752 | 32.7M USD | −56.8% reduced | Q3 2018 13 quarters |
| Oge Energy Corp | 0.2% | 978,102 | 32.2M USD | −20.7% reduced | Q3 2020 5 quarters |
| Cytomx Therapeutics Inc | 0.2% | 6,303,025 | 32.1M USD | −1.4% reduced | Q4 2020 4 quarters |
| UNP Union Pacific Corporation | 0.1% | 157,789 | 30.9M USD | −15.7% reduced | Q2 2021 2 quarters |
| SPDR Ser TR | 0.1% | 840,860 | 30.7M USD | −15.5% reduced | Q1 2020 7 quarters |
| Ultragenyx Pharmaceutical In | 0.1% | 340,374 | 30.7M USD | −51.9% reduced | Q4 2020 4 quarters |
| Dentsply Sirona Inc | 0.1% | 527,400 | 30.6M USD | −1.2% reduced | Q1 2021 3 quarters |
| LYV Live Nation Entertainment | 0.1% | 310,853 | 28.3M USD | −5.5% reduced | Q1 2021 3 quarters |
| Uniqure NV | 0.1% | 856,000 | 27.4M USD | −54.3% reduced | Q2 2020 6 quarters |
| DASH DoorDash | 0.1% | 131,814 | 27.2M USD | −59.8% reduced | Q2 2021 2 quarters |
| HUM Humana | 0.1% | 65,300 | 25.4M USD | −31.0% reduced | Q2 2020 6 quarters |
| BKR Baker Hughes | 0.1% | 1,019,546 | 25.2M USD | −14.4% reduced | Q2 2021 2 quarters |
| Mereo Biopharma Group PLC | 0.1% | 9,975,000 | 24.1M USD | −1.3% reduced | Q1 2021 3 quarters |
| DELL Dell Technologies | 0.1% | 220,100 | 22.9M USD | −32.0% reduced | Q2 2019 10 quarters |
| Liberty Global PLC | 0.1% | 772,800 | 22.8M USD | −15.2% reduced | Q1 2021 3 quarters |
| Horizon Therapeutics Pub L | 0.1% | 203,378 | 22.3M USD | −80.7% reduced | Q2 2021 2 quarters |
| Repligen Corp | 0.1% | 76,413 | 22.1M USD | −80.8% reduced | Q3 2018 13 quarters |
| Inspire Med Sys Inc | 0.1% | 91,945 | 21.4M USD | −54.7% reduced | Q4 2020 4 quarters |
| Takeda Pharmaceutical Co Ltd | 0.1% | 1,299,900 | 21.3M USD | −5.6% reduced | Q2 2021 2 quarters |
| VST Vistra Corp. | < 0.1% | 1,199,000 | 20.5M USD | −47.4% reduced | Q1 2021 3 quarters |
| Sentinelone Inc | < 0.1% | 363,800 | 19.5M USD | −44.0% reduced | Q2 2021 2 quarters |
| Texas Roadhouse Inc | < 0.1% | 213,176 | 19.5M USD | −52.1% reduced | Q1 2020 7 quarters |
| Ptc Therapeutics Inc | < 0.1% | 519,400 | 19.3M USD | −21.8% reduced | Q3 2018 13 quarters |
| Alnylam Pharmaceuticals Inc | < 0.1% | 99,512 | 18.8M USD | −16.9% reduced | Q4 2020 4 quarters |
| Darling Ingredients Inc | < 0.1% | 255,102 | 18.3M USD | −40.6% reduced | Q3 2020 5 quarters |
| HSY Hershey Company (The) | < 0.1% | 106,729 | 18.1M USD | −12.7% reduced | Q2 2020 6 quarters |
| Select Med HLDGS Corp | < 0.1% | 497,268 | 18.0M USD | −35.8% reduced | Q3 2019 9 quarters |
| Brightsphere Invt Group Inc | < 0.1% | 683,700 | 17.9M USD | −34.0% reduced | Q3 2019 9 quarters |
| Axogen Inc | < 0.1% | 1,124,337 | 17.8M USD | −10.1% reduced | Q4 2020 4 quarters |
| Prometheus Biosciences Inc | < 0.1% | 736,402 | 17.5M USD | −3.6% reduced | Q1 2021 3 quarters |
| AEP American Electric Power | < 0.1% | 209,800 | 17.0M USD | −77.5% reduced | Q2 2021 2 quarters |
| AMZN Amazon | < 0.1% | 5,012 | 16.5M USD | −96.6% reduced | Q1 2017 19 quarters |
| CSX CSX Corporation | < 0.1% | 547,822 | 16.3M USD | −77.6% reduced | Q3 2020 5 quarters |
| Travel Plus Leisure Co | < 0.1% | 289,700 | 15.8M USD | −14.2% reduced | Q1 2021 3 quarters |
| Digitalbridge Group Inc | < 0.1% | 2,602,900 | 15.7M USD | −36.0% reduced | Q2 2021 2 quarters |
| Restaurant Brands Intl Inc | < 0.1% | 246,766 | 15.1M USD | −41.0% reduced | Q2 2021 2 quarters |
| Roku Inc | < 0.1% | 47,004 | 14.7M USD | −66.1% reduced | Q2 2020 6 quarters |
| CDNS Cadence Design Systems | < 0.1% | 93,600 | 14.2M USD | −56.1% reduced | Q2 2021 2 quarters |
| PEG Public Service Enterprise Group | < 0.1% | 232,600 | 14.2M USD | −68.5% reduced | Q2 2021 2 quarters |
| CB Chubb Limited | < 0.1% | 79,458 | 13.8M USD | −59.4% reduced | Q2 2020 6 quarters |
| APA APA Corporation | < 0.1% | 625,524 | 13.4M USD | −10.0% reduced | Q1 2021 3 quarters |
| Farfetch Ltd | < 0.1% | 355,434 | 13.3M USD | −57.5% reduced | Q4 2020 4 quarters |
| Ringcentral Inc | < 0.1% | 59,800 | 13.0M USD | −58.5% reduced | Q2 2020 6 quarters |
| Dicerna Pharmaceuticals Inc | < 0.1% | 635,400 | 12.8M USD | −11.8% reduced | Q4 2020 4 quarters |
| Chinook Therapeutics Inc | < 0.1% | 994,870 | 12.7M USD | −33.4% reduced | Q4 2020 4 quarters |
| CHRW C.H. Robinson | < 0.1% | 145,900 | 12.7M USD | −14.1% reduced | Q2 2021 2 quarters |
| DHR Danaher Corporation | < 0.1% | 40,449 | 12.3M USD | −54.9% reduced | Q1 2020 7 quarters |
| Icici Bank Limited | < 0.1% | 650,341 | 12.3M USD | −54.7% reduced | Q1 2021 3 quarters |
| Caesars Entertainment Inc Ne | < 0.1% | 104,103 | 11.7M USD | −75.8% reduced | Q4 2020 4 quarters |
| Prothena Corp PLC | < 0.1% | 161,900 | 11.5M USD | −4.1% reduced | Q2 2021 2 quarters |
| TECH Bio-Techne | < 0.1% | 23,393 | 11.3M USD | −29.7% reduced | Q1 2021 3 quarters |
| PEP PepsiCo | < 0.1% | 74,375 | 11.2M USD | −78.3% reduced | Q1 2021 3 quarters |
| Array Technologies Inc | < 0.1% | 600,781 | 11.1M USD | −12.6% reduced | Q4 2020 4 quarters |
| Abercrombie & Fitch Co | < 0.1% | 290,031 | 10.9M USD | −2.1% reduced | Q2 2020 6 quarters |
| Vail Resorts Inc | < 0.1% | 32,263 | 10.8M USD | −58.6% reduced | Q2 2021 2 quarters |
| MAT Mattel | < 0.1% | 569,340 | 10.6M USD | −36.5% reduced | Q3 2020 5 quarters |
| West Pharmaceutical Svsc Inc | < 0.1% | 24,728 | 10.5M USD | −17.9% reduced | Q2 2019 10 quarters |
| Heska Corp | < 0.1% | 40,001 | 10.3M USD | −25.1% reduced | Q4 2020 4 quarters |
| V F Corp | < 0.1% | 152,575 | 10.2M USD | −83.3% reduced | Q4 2020 4 quarters |
| ASML ASML Holding (ADR) | < 0.1% | 13,500 | 10.1M USD | −70.8% reduced | Q3 2020 5 quarters |
| FANG Diamondback Energy | < 0.1% | 104,438 | 9.9M USD | −43.8% reduced | Q2 2021 2 quarters |
| Paya Holdings Inc | < 0.1% | 885,400 | 9.6M USD | −37.8% reduced | Q4 2020 4 quarters |
| Fortune Brands Home & Sec In | < 0.1% | 106,800 | 9.6M USD | −49.3% reduced | Q2 2021 2 quarters |
| Crinetics Pharmaceuticals In | < 0.1% | 449,800 | 9.5M USD | −36.5% reduced | Q2 2020 6 quarters |
| Angiodynamics Inc | < 0.1% | 357,532 | 9.3M USD | −50.2% reduced | Q4 2020 4 quarters |
| OTIS Otis Worldwide | < 0.1% | 111,292 | 9.2M USD | −64.9% reduced | Q1 2020 7 quarters |
| Despegar Com Corp | < 0.1% | 760,100 | 9.1M USD | −5.0% reduced | Q1 2021 3 quarters |
| Hydrofarm HLDGS Group Inc | < 0.1% | 239,600 | 9.1M USD | −16.9% reduced | Q4 2020 4 quarters |
| MS Morgan Stanley | < 0.1% | 93,200 | 9.1M USD | −59.9% reduced | Q1 2018 15 quarters |
| Curis Inc | < 0.1% | 1,156,743 | 9.1M USD | −77.5% reduced | Q4 2020 4 quarters |
| Pulmonx Corp | < 0.1% | 251,200 | 9.0M USD | −62.0% reduced | Q4 2020 4 quarters |
| SIRI Sirius XM | < 0.1% | 1,462,395 | 8.9M USD | −64.3% reduced | Q2 2021 2 quarters |
| LIN Linde plc | < 0.1% | 29,825 | 8.8M USD | −29.8% reduced | Q2 2021 2 quarters |
| BIIB Biogen | < 0.1% | 30,852 | 8.7M USD | −87.4% reduced | Q3 2020 5 quarters |
| Kohls Corp | < 0.1% | 183,737 | 8.7M USD | −68.4% reduced | Q1 2021 3 quarters |
| Cogent Biosciences Inc | < 0.1% | 1,005,303 | 8.5M USD | −32.2% reduced | Q4 2020 4 quarters |
| RUN Sunrun | < 0.1% | 189,547 | 8.3M USD | −68.5% reduced | Q4 2020 4 quarters |
| West Fraser Timber Co Ltd | < 0.1% | 95,000 | 8.0M USD | −5.0% reduced | Q1 2021 3 quarters |
| DLTR Dollar Tree | < 0.1% | 82,985 | 7.9M USD | −41.1% reduced | Q2 2020 6 quarters |
| Caredx Inc | < 0.1% | 123,400 | 7.8M USD | −25.6% reduced | Q2 2021 2 quarters |
| Trex Co Inc | < 0.1% | 76,000 | 7.7M USD | −46.4% reduced | Q2 2020 6 quarters |
| Inari Med Inc | < 0.1% | 95,400 | 7.7M USD | −33.8% reduced | Q2 2021 2 quarters |
| Myriad Genetics Inc | < 0.1% | 239,493 | 7.7M USD | −37.3% reduced | Q3 2020 5 quarters |
| Herbalife Nutrition Ltd | < 0.1% | 181,532 | 7.7M USD | −31.3% reduced | Q4 2020 4 quarters |
| Transalta Corp | < 0.1% | 725,000 | 7.7M USD | −43.1% reduced | Q3 2020 5 quarters |
| Evoqua Water Technologies Co | < 0.1% | 202,548 | 7.6M USD | −51.0% reduced | Q2 2021 2 quarters |
| ABT Abbott Laboratories | < 0.1% | 64,300 | 7.6M USD | −6.5% reduced | Q2 2021 2 quarters |
| Childrens Pl Inc New | < 0.1% | 99,022 | 7.5M USD | −14.6% reduced | Q1 2019 11 quarters |
| Mogo Inc | < 0.1% | 1,723,710 | 7.4M USD | −4.8% reduced | Q1 2021 3 quarters |
| Tempur Sealy Intl Inc | < 0.1% | 159,100 | 7.4M USD | −42.4% reduced | Q1 2019 11 quarters |
| Ionis Pharmaceuticals Inc | < 0.1% | 219,300 | 7.4M USD | −77.6% reduced | Q2 2021 2 quarters |
| Cyrusone Inc | < 0.1% | 93,263 | 7.2M USD | −27.2% reduced | Q2 2021 2 quarters |
| F-Star Therapeutics Inc | < 0.1% | 981,249 | 7.2M USD | −8.7% reduced | Q1 2021 3 quarters |
| Oshkosh Corp | < 0.1% | 70,000 | 7.2M USD | −29.3% reduced | Q4 2020 4 quarters |
| Royal Dutch Shell PLC | < 0.1% | 159,691 | 7.1M USD | −88.5% reduced | Q2 2020 6 quarters |
| Sutro Biopharma Inc | < 0.1% | 375,000 | 7.1M USD | −67.0% reduced | Q2 2020 6 quarters |
| Aclaris Therapeutics Inc | < 0.1% | 391,300 | 7.0M USD | −18.2% reduced | Q1 2021 3 quarters |
| Oric Pharmaceuticals Inc | < 0.1% | 333,782 | 7.0M USD | −64.6% reduced | Q1 2021 3 quarters |
| Stmicroelectronics N V | < 0.1% | 155,838 | 6.8M USD | −89.2% reduced | Q2 2020 6 quarters |
| Fusion Pharmaceuticals Inc | < 0.1% | 858,012 | 6.8M USD | −2.0% reduced | Q4 2020 4 quarters |
| Western Alliance Bancorp | < 0.1% | 62,000 | 6.7M USD | −35.1% reduced | Q1 2021 3 quarters |
| Post HLDGS Inc | < 0.1% | 60,564 | 6.7M USD | −5.0% reduced | Q4 2020 4 quarters |
| ROP Roper Technologies | < 0.1% | 14,700 | 6.6M USD | −36.6% reduced | Q1 2021 3 quarters |
| AZO AutoZone | < 0.1% | 3,853 | 6.5M USD | −84.9% reduced | Q1 2020 7 quarters |
| ALLE Allegion | < 0.1% | 47,506 | 6.3M USD | −35.3% reduced | Q2 2021 2 quarters |
| ARES Ares Management | < 0.1% | 85,000 | 6.3M USD | −38.9% reduced | Q2 2021 2 quarters |
| Cimarex Energy Co | < 0.1% | 71,255 | 6.2M USD | −91.8% reduced | Q1 2016 23 quarters |
| SCHW Charles Schwab Corporation | < 0.1% | 85,300 | 6.2M USD | −72.3% reduced | Q2 2021 2 quarters |
| Galapagos NV | < 0.1% | 117,900 | 6.2M USD | −83.4% reduced | Q4 2020 4 quarters |
| Keros Therapeutics Inc | < 0.1% | 148,600 | 5.9M USD | −63.1% reduced | Q2 2020 6 quarters |
| Adamas Pharmaceuticals Inc | < 0.1% | 1,150,000 | 5.6M USD | −48.9% reduced | Q2 2021 2 quarters |
| Under Armour Inc | < 0.1% | 316,700 | 5.5M USD | −8.3% reduced | Q1 2021 3 quarters |
| Tenaris S A | < 0.1% | 259,977 | 5.5M USD | −43.1% reduced | Q1 2021 3 quarters |
| Option Care Health Inc | < 0.1% | 224,700 | 5.5M USD | −19.8% reduced | Q2 2021 2 quarters |
| CRL Charles River Laboratories | < 0.1% | 12,894 | 5.3M USD | −71.6% reduced | Q3 2020 5 quarters |
| Allakos Inc | < 0.1% | 49,200 | 5.2M USD | −80.1% reduced | Q1 2021 3 quarters |
| Globus Med Inc | < 0.1% | 67,900 | 5.2M USD | −56.4% reduced | Q2 2020 6 quarters |
| Genius Sports Limited | < 0.1% | 245,200 | 4.6M USD | −63.7% reduced | Q2 2021 2 quarters |
| Royal Dutch Shell PLC | < 0.1% | 101,896 | 4.5M USD | −94.4% reduced | Q3 2020 5 quarters |
| DVA DaVita | < 0.1% | 37,100 | 4.3M USD | −88.2% reduced | Q2 2021 2 quarters |
| Cerevel Therapeutics Hldng I | < 0.1% | 141,400 | 4.2M USD | −61.6% reduced | Q4 2020 4 quarters |
| ULTA Ulta Beauty | < 0.1% | 11,205 | 4.0M USD | −93.5% reduced | Q1 2021 3 quarters |
| Tronox Holdings PLC | < 0.1% | 162,900 | 4.0M USD | −73.7% reduced | Q4 2020 4 quarters |
| CMS CMS Energy | < 0.1% | 66,408 | 4.0M USD | −95.3% reduced | Q4 2020 4 quarters |
| Orthopediatrics Corp | < 0.1% | 59,475 | 3.9M USD | −39.4% reduced | Q1 2021 3 quarters |
| Green Plains Inc | < 0.1% | 118,100 | 3.9M USD | −48.7% reduced | Q1 2021 3 quarters |
| Arbutus Biopharma Corp | < 0.1% | 895,200 | 3.8M USD | −10.5% reduced | Q1 2021 3 quarters |
| EVRG Evergy | < 0.1% | 61,389 | 3.8M USD | −65.4% reduced | Q4 2020 4 quarters |
| Modivcare Inc | < 0.1% | 20,700 | 3.8M USD | −44.7% reduced | Q1 2021 3 quarters |
| Ftc Solar Inc | < 0.1% | 467,579 | 3.6M USD | −2.2% reduced | Q2 2021 2 quarters |
| Merus N V | < 0.1% | 164,150 | 3.6M USD | −0.1% reduced | Q2 2021 2 quarters |
| Bruker Corp | < 0.1% | 45,993 | 3.6M USD | −35.1% reduced | Q2 2021 2 quarters |
| NI NiSource | < 0.1% | 142,300 | 3.4M USD | −85.4% reduced | Q2 2021 2 quarters |
| XPEV XPeng | < 0.1% | 93,800 | 3.3M USD | −71.2% reduced | Q2 2021 2 quarters |
| Zillow Group Inc | < 0.1% | 35,551 | 3.1M USD | −87.7% reduced | Q2 2020 6 quarters |
| Varex Imaging Corp | < 0.1% | 108,792 | 3.1M USD | −69.6% reduced | Q4 2020 4 quarters |
| Madison Square Grdn Sprt Cor | < 0.1% | 16,000 | 3.0M USD | −31.2% reduced | Q3 2020 5 quarters |
| Eagle Matls Inc | < 0.1% | 21,805 | 2.9M USD | −71.2% reduced | Q3 2020 5 quarters |
| Vimeo Inc | < 0.1% | 96,114 | 2.8M USD | −88.9% reduced | Q2 2021 2 quarters |
| Pbf Energy Inc | < 0.1% | 217,100 | 2.8M USD | −64.5% reduced | Q2 2021 2 quarters |
| Outset Med Inc | < 0.1% | 53,497 | 2.6M USD | −52.8% reduced | Q2 2021 2 quarters |
| Canadian Nat Res Ltd | < 0.1% | 70,000 | 2.6M USD | −91.0% reduced | Q2 2017 18 quarters |
| Genmab A/S | < 0.1% | 56,600 | 2.5M USD | −87.2% reduced | Q1 2021 3 quarters |
| BAX Baxter International | < 0.1% | 30,600 | 2.5M USD | −95.1% reduced | Q2 2019 10 quarters |
| BNY BNY Mellon | < 0.1% | 46,100 | 2.4M USD | −93.5% reduced | Q3 2019 9 quarters |
| Acorda Therapeutics Inc | < 0.1% | 468,166 | 2.2M USD | −47.3% reduced | Q1 2021 3 quarters |
| Tenet Healthcare Corp | < 0.1% | 30,432 | 2.0M USD | −81.1% reduced | Q1 2021 3 quarters |
| Apollo Strategic Growth Capt | < 0.1% | 200,000 | 2.0M USD | −59.4% reduced | Q1 2021 3 quarters |
| Deciphera Pharmaceuticals In | < 0.1% | 50,926 | 1.7M USD | −69.3% reduced | Q2 2021 2 quarters |
| Allison Transmission HLDGS I | < 0.1% | 44,300 | 1.6M USD | −8.3% reduced | Q1 2021 3 quarters |
| Blue Owl Capital Inc | < 0.1% | 100,000 | 1.6M USD | −83.2% reduced | Q2 2021 2 quarters |
| Ac Immune SA | < 0.1% | 228,000 | 1.5M USD | −39.5% reduced | Q2 2021 2 quarters |
| Revolution Medicines Inc | < 0.1% | 55,000 | 1.5M USD | −71.4% reduced | Q2 2021 2 quarters |
| OXY Occidental Petroleum | < 0.1% | 47,768 | 1.4M USD | −95.2% reduced | Q1 2021 3 quarters |
| Poshmark Inc | < 0.1% | 57,000 | 1.4M USD | −71.6% reduced | Q2 2021 2 quarters |
| Euronet Worldwide Inc | < 0.1% | 10,600 | 1.3M USD | −96.6% reduced | Q1 2021 3 quarters |
| Nanostring Technologies Inc | < 0.1% | 27,800 | 1.3M USD | −92.2% reduced | Q3 2020 5 quarters |
| Avrobio Inc | < 0.1% | 230,000 | 1.3M USD | −55.3% reduced | Q1 2021 3 quarters |
| Purple Biotech Ltd | < 0.1% | 279,294 | 1.3M USD | −46.8% reduced | Q2 2021 2 quarters |
| ABNB Airbnb | < 0.1% | 7,478 | 1.3M USD | −78.3% reduced | Q2 2021 2 quarters |
| Cable One Inc | < 0.1% | 668 | 1.2M USD | −95.9% reduced | Q2 2021 2 quarters |
| Canaan Inc | < 0.1% | 179,000 | 1.1M USD | −52.6% reduced | Q1 2021 3 quarters |
| Monro Inc | < 0.1% | 18,100 | 1.0M USD | −83.8% reduced | Q1 2021 3 quarters |
| ISRG Intuitive Surgical | < 0.1% | 952 | 946.0K USD | −97.9% reduced | Q1 2021 3 quarters |
| Sibanye Stillwater Ltd | < 0.1% | 76,200 | 940.0K USD | −89.7% reduced | Q3 2020 5 quarters |
| Itron Inc | < 0.1% | 11,100 | 839.0K USD | −72.2% reduced | Q1 2021 3 quarters |
| Hologic Inc | < 0.1% | 11,300 | 834.0K USD | −41.8% reduced | Q2 2021 2 quarters |
| Adient PLC | < 0.1% | 19,500 | 808.0K USD | −95.0% reduced | Q1 2021 3 quarters |
| Tivity Health Inc | < 0.1% | 34,300 | 791.0K USD | −95.1% reduced | Q1 2021 3 quarters |
| Bellus Health Inc New | < 0.1% | 124,278 | 763.0K USD | −97.3% reduced | Q4 2020 4 quarters |
| First Advantage Corp New | < 0.1% | 38,000 | 724.0K USD | −24.0% reduced | Q2 2021 2 quarters |
| Healthcare Rlty TR | < 0.1% | 23,300 | 694.0K USD | −51.6% reduced | Q2 2021 2 quarters |
| Zumiez Inc | < 0.1% | 17,300 | 688.0K USD | −86.7% reduced | Q1 2021 3 quarters |
| Payoneer Global Inc | < 0.1% | 73,000 | 624.0K USD | −97.1% reduced | Q2 2021 2 quarters |
| LVS Las Vegas Sands | < 0.1% | 11,900 | 436.0K USD | −98.3% reduced | Q3 2018 13 quarters |
| Romeo Power Inc | < 0.1% | 86,400 | 428.0K USD | −27.9% reduced | Q2 2021 2 quarters |
| Edgewell Pers Care Co | < 0.1% | 11,700 | 425.0K USD | −84.5% reduced | Q2 2021 2 quarters |
| TCOM Trip.com Group | < 0.1% | 13,314 | 409.0K USD | −89.9% reduced | Q2 2021 2 quarters |
| Adaptimmune Therapeutics PLC | < 0.1% | 76,300 | 394.0K USD | −96.3% reduced | Q4 2020 4 quarters |
| Gemini Therapeutics Inc | < 0.1% | 93,576 | 378.0K USD | −53.2% reduced | Q1 2021 3 quarters |
| Selectquote Inc | < 0.1% | 28,600 | 370.0K USD | −92.2% reduced | Q2 2020 6 quarters |
| Sociedad Quimica Y Minera De | < 0.1% | 6,300 | 338.0K USD | −97.4% reduced | Q2 2021 2 quarters |
| Cerner Corp | < 0.1% | 4,400 | 310.0K USD | −99.4% reduced | Q1 2021 3 quarters |
| Petco Health & Wellness Co I | < 0.1% | 13,392 | 283.0K USD | −88.9% reduced | Q2 2021 2 quarters |
| Harmony Biosciences HLDGS In | < 0.1% | 6,753 | 259.0K USD | −94.1% reduced | Q2 2021 2 quarters |
| Allete Inc | < 0.1% | 4,000 | 238.0K USD | −80.3% reduced | Q2 2020 6 quarters |
| Verint Sys Inc | < 0.1% | 3,300 | 148.0K USD | −98.2% reduced | Q4 2020 4 quarters |
| Graphite Bio Inc | < 0.1% | 5,000 | 82.0K USD | −50.0% reduced | Q2 2021 2 quarters |
| Dmy Technology Group Inc III | < 0.1% | 20,000 | 69.0K USD | −73.3% reduced | Q1 2021 3 quarters |
| E L F Beauty Inc | < 0.1% | 1,704 | 50.0K USD | −99.3% reduced | Q2 2020 6 quarters |
| Triterras Inc | < 0.1% | 12,512 | 10.0K USD | −99.1% reduced | Q4 2020 4 quarters |
| Cameco Corp | < 0.1% | 200 | 4.0K USD | −98.6% reduced | Q1 2021 3 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 59 option positions, value of the underlying shares as reported 1.7B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 790.7M USD
- Merck & Co. Call 67.6M USD
- Ishares TR Put 65.6M USD
- IBM Call 59.1M USD
- DraftKings Call 57.8M USD
- Uber Call 51.5M USD
- Las Vegas Sands Call 49.1M USD
- AppLovin Put 38.0M USD
- Alibaba Group (ADR) Call 33.5M USD
- SPDR Ser TR Put 29.0M USD
Breakdown by sector
- Technology 13.1%
- Financials 5.9%
- Industrials 5.7%
- Consumer Discretionary 4.6%
- Health Care 4.5%
- Communication Services 3.3%
- Consumer Staples 2.7%
- Utilities 1.9%
- Energy 1.3%
- Materials 0.8%
- Real Estate 0.2%
- not in our coverage 56.0%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors